Skip to content
OpenCapital
Get started

Rallybio Corporation RLYB Q1 2026 earnings

Reported May 13, 2026 · Before market open

Revenue$212.0KIn line
EPS-$1.46Miss by $0.26
Revenue estimate$212.0K
EPS estimate-$1.20

Next report

Aug 6, 2026 (In 1 week)
Revenue estimate$216.5K
EPS estimate-$1.28

Versus estimates

Revenue

Q1 2026$212.0KIn line
Q4 2025$222.0KBeat by $122.0KQ3 2025$212.0KBeat by $145.3KQ2 2025$212.0KBeat by $145.3KQ1 2025$212.0KQ4 2024$38.0KMiss by $111.5K

Diluted EPS

Q1 2026-$1.46Miss by $0.26
Q4 2025-$1.28Miss by $0.04Q3 2025-$0.14Beat by $0.11Q2 2025-$0.22Miss by $0.02Q1 2025-$0.21In lineQ4 2024-$0.25Beat by $0.02

Ask the moment Rallybio Corporation reports.

Connect your AI and ask the moment the filing drops. It reads the release, surfaces what management said, and gives you its own read.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

When did Rallybio Corporation report Q1 2026 earnings?
Rallybio Corporation (RLYB) reported Q1 2026 earnings on May 13, 2026 before market open.
What were Rallybio Corporation's Q1 2026 revenue and EPS?
Rallybio Corporation reported revenue of $212.0K and eps of $-1.46 for Q1 2026.
Did Rallybio Corporation beat estimates in Q1 2026?
Revenue beat the consensus estimate of $212.0K by -. EPS missed the consensus estimate of $-1.20 by $0.26.
How did Rallybio Corporation's Q1 2026 results compare year-over-year?
Compared to the same quarter a year prior, revenue grew 0.0% from $212.0K a year earlier and eps declined 595.2% from $-0.21.
Where can I find Rallybio Corporation's Q1 2026 SEC filings?
You can read the 10-Q periodic report (0001628280-26-034580) directly on SEC EDGAR. The filing index links above go to sec.gov.